Liver tumors and possible preneoplastic lesions, induced by a food-derived heterocyclic amine in cynomolgus monkeys; a study of histology and cytokeratin expression

Liver

Volumn 16, Issue 2, 1996, Pages 71-83

  Thergeirsson, U P ^a   Gomez, D E ^a   Lindsay, C K ^a   Simba, C C ^a   Adamson, R H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinoma; Cytokeratins; Heterocyclic amines; Histology; Liver; Monkey

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; CYTOKERATIN; GLYCOGEN; HETEROCYCLIC AMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CANCER INVASION; CELL PROLIFERATION; CLEAR CELL CARCINOMA; FOOD CONTAMINATION; HISTOGENESIS; HISTOLOGY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER TUMOR; METASTASIS; MONKEY; NONHUMAN; PRECANCER;

EID: 0029960926     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00708.x     Document Type: Article

References (41)

1. ROE F J C,. Liver tumors in rodents: extrapolation to man. Adv Vet Sci Comp Med 1987: 31: 45-68.
2. FARBER E, SARMA D S R. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987: 56: 4-22.
3. SELL S, HUNT J M, KNOLL B J, DUNSFORD H A. Cellular events during hepato-carcinogenesis in rats and the question of premalignancy. Adv Cancer Res 1987: 48: 37-111.
4. EVARTS R P, NAGY R NAKATSUKASA H, MARSDEN E, THORGEIRSSON S S. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res 1989: 49: 1541-1547.
5. BANNASCH P. Phenotypic cellular changes as indicators of stages during neoplastic development. In: Iverson O H, ed. Theories of carcinogenesis. Washington: Hemisphere Publishing Corporation, 1988: 231-249.
6. SUGIMURA T. Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat Res 1985: 150: 33-41.
7. FELTON J S, KNIZE M G. Heterocyclic-amine mutagens/carcinogens in foods. In: Cooper S C, Grover P L, eds. Handbook of experimental pharmacology, Vol. 94/I. New York: Springer-Verlag, 1990: 471-502.
8. WAKABAYASHI K, NAGAO M, ESUMI H, SUGIMURA T. Food-derived mutagens and carcinogens. Cancer Res (Suppl) 1992: 52: 20925-20985.
9. JAGERSTAD M, SKOG K, GRIVAS S, OLSON K. Formation of heterocyclic amines using model systems. Mutat Res 1991: 259: 219-233.
10. KATO R, YAMAZOE Y. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Gann 1987: 78: 297-311.
11. MCMANUS M E, BURGESS W, SNYDERWINE E, STUPANS I. Specificity of rabbit cytochrome P450 isozymes involved in the metabolic activation of the food derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline. Cancer Res 1988: 48: 4513-4519.
12. 32P-postlabeling method to detect DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in monkeys fed IQ: Identification of the N-(deoxyguanosin-8-yll)-IQ adduct. Carcinogenesis 1988: 9: 1739-1743.
13. OHGAKI H, KUSAMA K, MATSUKURA N, et al. Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 1984: 5: 921-924.
14. TAKAYAMA S, NAKATSURU Y, MASUDA M, OHGAKI H, SATO S, SUGIMURA T. Demonstration of carcinogenicity in F344 rats of 2-amino-3-methylimidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Gann 1984: 75: 467-470.
15. 1 Bisceglie A, Purcell R H, eds. Etiology, pathology and treatment of hepatocellular carcinoma in North America. Houston-London: Gulf Publ. Co, 1991: 35-54.
16. VAN EYKEN P, DESMET V J. Cytokeratins and the liver (Review). Liver 1993: 13: 113-122.
17. VAN EYKEN P, SCIOT R, PATERSON A, CALLEA F, KEW M C, DESMET V J. Cytokeratin expression in hepatocellular carcinoma. Hum Pathol 1988: 19: 562-568.
18. ADAMSON R H, THORGEIRSSON U P, SNYDERWINE E G. et al. Carcinogenicity of 2-amino-3-methylimidazo[4,5-f)quinoline in non-human primates: induction of tumor in three macaques. Jpn J Cancer Res 1990: 81: 10-14.
19. CRAIG J R, PETERS R L. EDMONDSON H A. eds. Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, 2nd Series, Fascicle 26. Washington DC: Armed Forces Institute of Pathology, 1989: 123-212.
20. THORGEIRSSON U P, DALGARD D W, REEVES J, ADAMSON R H. Tumor incidence in a chemical carcinogenesis study of non-human primates. Regul Toxicol Pharmacol 1994: 19: 130-151.
21. DAOUST R, CALAMAI R. Hyperbasophilic foci as sites of neoplastic transformation in hepatic parenchyma. Cancer Res 1971: 31: 1290-1296.
22. SOLT D B, FARBER E. New principle for the analysis of chemical carcinogenesis. Nature (Lond) 1976: 263: 701-703.
23. MOORE M A, MAYER D. BANNASCH P. The dose dependence and sequential appearance of putative preneoplastic population induced in the rat liver by stop experiments with N-nitrosomorpholine. Carcinogenesis 1982: 3: 1429-1436.
24. RUEBNER B H, MICHAS C, KANAYAMA R, BAMNASCH P. Sequential hepatic histologic and histochemical changes produced by diethylnitrosamine in the rhesus monkey. J Natl Cancer Inst 1976: 57. 1261-1267.
25. KARHUNEN P J, PENTTILA A. Preneoplastic lesions of human liver. Hepatogastroenterol 1987: 34: 10-15.
26. CORTINOVIS C, KLIMEK F, NOGUEIRA E. Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. Am J Pathol 1991: 139: 1157-1171.
27. BANNASCH P, ENZMANN H, HACKER H J, WEBER E, ZERBAN H. Comparative pathobiology of hepatic preneoplasia. In: Bannasch P, Keppler D, Weber G, eds. Liver cell carcinoma. Dordrecht, Boston, London: Kluwer Academic Publishers, 1989: 53-73.
28. 1. Carcinogenesis 1985: 6: 1641-1648.
29. BARBASON H, BETZ E H. Proliferation of preneoplastic lesions after discontinuation of chronic DEN feeding in the development of hepatomas in rat. Br J Cancer 1981: 44: 561-566.
30. ZERBAN H, RADIG S, KOPP-SCHNEIDER A, BANNASCH P. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Carcinogenesis 1994: 15: 2467-2473.
31. ANTHONY P P, VOGEL C L, BARKER L F. Liver cell dysplasia. a premalignant condition. J Clin Pathol 1973: 26: 217-223.
32. WATANABE S, OKITA K, HARADA T. Morphologic studies of liver cell dysplasia. Cancer 1983: 51: 2197-2205.
33. LEMIRE J M, SHIOJIRI N, FAUSTO N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol 1991: 139: 535-552.
34. TSAO M S, GRISHAM J W. Hepatocarcinomas, cholangiocarcinomas and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells: a light- and electron-microscopic analysis. Am J Pathol 1987: 127: 168-181.
35. EVARTS R P, NAKATSUKASA H, MARSDEN E R, HSIA C C, DUNSFORD H A, THORGEIRSSON S S. Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat. Cancer Res 1990: 50: 3439-3444.
36. STEINBERG P, STEINBRECHER R. RADAEVA S, et al. Oval cell lines OC/CDE6 and OC/CDE22 gives rise to cholangiocellular and undifferentiated carcinomas. Lab Invest 1994: 71: 700-709.
37. BLANKENSHIP L J, MANNING F C R, ORENSTEIN J M, PATIERNO S R. Apoptosis is the mode of cell death caused by carcinogenic chromium. Toxicol Appl Pharmacol 1994: 126: 75-83.
38. BATTIFORA H. Diagnostic uses of antibodies to keratins: a review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. In: Fenoglio-Preiser C M, Wolff M, Rilke F, eds. Progress in surgical pathology. Philadelphia: Field and Wood, 1988, 8: 1-15.
39. VAN EYKEN P, SCIOT R, CALLEA F, VAN DER STEEN K, MOERMAN P, DESMET V J. The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology 1988: 8: 1586-1595.
40. BUTRON VILA M M, HAOT J, DESMET V J. Cholestatic features in focal nodular hyperplasia of the liver. Liver 1984: 4: 387-395.
41. MOLL R, FRANKE W W, SCHILLER D L, GEIGER B, KREPLER R. The catalogue of human cytokeratin polypeptides: patterns of expression of specific cytokerains in normal epithelia, tumors and cultured cells. Cell 1982: 31: 11-24.